Warning factors of metachronous uterine cancer in patients with breast cancer: a real-world nationwide cohort study

Graphical abstract

• Publication year

  2025

• Venue

  Gynecologic Oncology Reports

• Publication date

  2025-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.gore.2025.101732PMID 40270980PMCID 12013394
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Second Primary Breast Cancer in Young Breast Cancer Survivors.

  2024cited by this paper
• Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

  2024cited by this paper
• Trends in Incidence Rates, Mortality Rates, and Age-Period-Cohort Effects of Female Breast Cancer — China, 2003–2017

  2023cited by this paper
• Tamoxifen use and risk of endometrial cancer in breast cancer patients: A systematic review and dose–response meta‐analysis

  2023cited by this paper
• Predicting risk of endometrial cancer in asymptomatic women (PRECISION): Model development and external validation

  2023cited by this paper
• Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Recurrence in Breast Noninvasive Neoplasia: A 10-Year Follow-Up of TAM-01 Study

  2023cited by this paper
• Risk of Endometrial Polyps, Hyperplasia, Carcinoma, and Uterine Cancer After Tamoxifen Treatment in Premenopausal Women With Breast Cancer

  2022cited by this paper
• Forecast of a future leveling of the incidence trends of female breast cancer in Taiwan: an age-period-cohort analysis

  2022cited by this paper
• Risks of subsequent primary cancers among breast cancer survivors according to hormone receptor status

  2021cited by this paper
• Age-specific trend and birth cohort effect on different histologic types of uterine corpus cancers

  2021cited by this paper
• Risk of Endometrial Cancer and Frequencies of Invasive Endometrial Procedures in Young Breast Cancer Survivors Treated With Tamoxifen: A Nationwide Study

  2021cited by this paper
• Cost-Effectiveness of Early Detection and Prevention Strategies for Endometrial Cancer—A Systematic Review

  2020cited by this paper
• Younger tamoxifen-treated breast cancer patients also had higher risk of endometrial cancer and the risk could be reduced by sequenced aromatase inhibitor use: A population-based study in Taiwan

  2019cited by this paper
• Taiwan's Nationwide Cancer Registry System of 40 years: Past, present, and future.

  2019influential reference
• Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial

  2016influential reference
• Risk of second cancers cancer after a first primary breast cancer: a systematic review and meta-analysis.

  2015cited by this paper
• An epidemiological model for prediction of endometrial cancer risk in Europe

  2015cited by this paper
• Endometrial Cancer Incidence in Breast Cancer Patients Correlating with Age and Duration of Tamoxifen Use: a Population Based Study

  2014cited by this paper
• Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial

  2013cited by this paper
• Risk Prediction for Breast, Endometrial, and Ovarian Cancer in White Women Aged 50 y or Older: Derivation and Validation from Population-Based Cohort Studies

  2013cited by this paper
• Risk of second primary cancer among women with breast cancer: a population-based study in Granada (Spain).

  2013cited by this paper
• The emerging epidemic of estrogen‐related cancers in young women in a developing Asian country

  2012cited by this paper
• The endometrium in asymptomatic breast cancer patients on tamoxifen: value of transvaginal ultrasonography with saline infusion and Doppler flow.

  2004cited by this paper
• World Health Organization Classification of Tumours

  2002cited by this paper
• TAMOXIFEN TREATMENT AND GYNECOLOGIC SIDE EFFECTS: A REVIEW

  2001influential reference
• Hormonal Pathology of the Endometrium

  2000cited by this paper
• Identification of women at high risk of developing endometrial cancer on tamoxifen.

  2000cited by this paper
• Significance of endovaginal ultrasonography in assessing tamoxifen‐associated changes of the endometrium

  2000cited by this paper
• Endometrial thickness in tamoxifen-treated patients: an independent predictor of endometrial disease.

  1999cited by this paper
• Diagnostic pitfalls of ultrasonographic uterine screening in women treated with tamoxifen.

  1994cited by this paper

• No citing papers are available for this paper.